Shanghai Nianxing Industrial Co., Ltd
China
Product Name: M435-1279
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

DC Chemicals Limited
China
Product Name: M435-1279
Price: $500.0/100mg
Purity: 98.0%
Stocking Period: 1 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

1359431-16-5

1359431-16-5 structure

1359431-16-5 structure

Name: M435-1279
Chemical Name: M435-1279
CAS Number: 1359431-16-5
Molecular Formula: C₁₈H₁₇N₃O₅S₂
Molecular Weight: 419.47
Catalog: Signaling Pathways Metabolic Enzyme/Protease E1/E2/E3 Enzyme
Create Date: 2022-01-11 13:20:58
Modify Date: 2024-01-09 19:11:18
M435-1279 is a UBE2T inhibitor. M435-1279 acts inhibit the Wnt/β-catenin signaling pathway hyperactivation through blocking UBE2T-mediated degradation of RACK1[1].

Name	M435-1279

Description	M435-1279 is a UBE2T inhibitor. M435-1279 acts inhibit the Wnt/β-catenin signaling pathway hyperactivation through blocking UBE2T-mediated degradation of RACK1[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Metabolic Enzyme/Protease >> E1/E2/E3 Enzyme
Target	UBE2T
In Vitro	M435-1279 (0, 2, 4, 8, 16, 31 μM; 48 h) significantly inhibits the growth of HGC27, AGS, and MKN45 cells[1]. M435-1279 (0, 4, 8, 12, 16, 20 μM) inhibits the cell viability whit a IC50 s of 16.8, 11.88, 6.93, 7.76 μM of GES-1, HGC27, MKN45, AGS cells, respectively[1]. M435-1279 (31 nM to 500 μM) binding to UBE2T whit a KD value of 50.5 μM[1]. M435-1279 has high LD50 (15.6 g/kg), LOAEL (0.207g/kg), and has a EC50 value of 7.47mg/L[1]. M435-1279 (11.88 μM; 48 h) inhibits the ubiquitination of RACK1 and the hyperactivation of the Wnt/β-catenin pathway[1]. Cell Viability Assay[1] Cell Line: HGC27, AGS, and MKN45 cells Concentration: 0, 2, 4, 8, 16, 31 μM Incubation Time: 48 h Result: Inhibited the cell growth. Cell Viability Assay[1] Cell Line: HGC27, AGS, and MKN45 cells Concentration: 0, 4, 8, 12, 16, 20 μM Incubation Time: Result: Inhibited the cell viability whit a IC50s of 16.8, 11.88, 6.93, 7.76 μM in GES-1, HGC27, MKN45, AGS cells, respectively.
In Vivo	M435-1279 (5 mg/kg/day; intratumor injections for 18 days) slows the tumor growth. M435-1279 induces higher RACK1 proteins expression, and lower Ki-67 and β-catenin proteins expression in intratumor tumors[1]. Animal Model: BALB/C nude mice CDX model (MKN45 tumor size: 75–100 mm3) [1] Dosage: 5 mg/kg/day Administration: intratumor injections for 18 days Result: Slowed the tumor growth. Induced higher RACK1 proteins expression, and lower Ki-67 and β-catenin proteins expression in intratumor tumors.
References	[1]. [1] Yu Z, et al. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene. 2021 Feb;40(5):1027-1042. doi: 10.1038/s41388-020-01572-w. Epub 2020 Dec 15. Erratum in: Oncogene. 2021 Apr;40(14):2622-2623.

Molecular Formula	C₁₈H₁₇N₃O₅S₂
Molecular Weight	419.47

Hazard Codes	Xi

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.